文献速递心律失常心力衰竭与心肌病

利用实时远程监测预测恶性室性心律失常

Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

本研究为IMPACT试验的事后分析,纳入2,413例植入ICD或CRT-D的心衰患者,利用设备治疗前30天的远程监测数据构建逻辑回归和神经网络模型预测恰当ICD治疗。逻辑回归模型AUC为0.72,神经网络模型AUC达0.90,后者还能识别心房导线阻抗、平均心率和患者活动的变化模式。

要点

  • 远程监测数据可用于预测30天内的恶性室性心律失常。
  • 神经网络模型预测性能优于传统逻辑回归(AUC 0.90 vs 0.72)。
  • 电击导线阻抗和室性早搏与恰当治疗风险增加相关。

核心结论

  • 每日远程监测数据可用于预测设备治疗前30天内的恶性室性心律失常。
  • 神经网络可补充并增强传统风险分层方法。

研究设计与样本

  • IMPACT随机对照试验的事后分析,共纳入2,718例植入ICD或CRT-D的心衰患者。
  • 最终分析纳入2,413例患者,年龄64±11岁,26%为女性,64%植入ICD。
  • 利用设备治疗前30天的远程监测数据构建多变量逻辑回归和神经网络模型。

主要发现

  • 共分析59,807次设备传输数据,151例患者接受了恰当设备治疗(141次电击,10次抗心动过速起搏)。
  • 逻辑回归模型识别电击导线阻抗和室性早搏与恰当治疗风险增加显著相关(敏感性39%,特异性91%,AUC 0.72)。
  • 神经网络模型预测性能显著更优(P < 0.01),敏感性54%,特异性96%,AUC 0.90。
  • 神经网络还识别心房导线阻抗、平均心率和患者活动的变化模式作为恰当治疗的预测因子。

临床怎么用

  • 对于植入ICD或CRT-D的心衰患者,可利用每日远程监测数据辅助预测恶性室性心律失常风险。
  • 神经网络模型可能提升传统风险分层的预测性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although implantable cardioverter-defibrillator (ICD) therapies are associated with increased morbidity and mortality, the prediction of malignant ventricular arrhythmias has remained elusive. OBJECTIVES: The purpose of this study was to evaluate whether daily remote-monitoring data may predict appropriate ICD therapies for ventricular tachycardia or ventricular fibrillation. METHODS: This was a post hoc analysis of IMPACT (Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices), a multicenter, randomized, controlled trial of 2,718 patients evaluating atrial tachyarrhythmias and anticoagulation for patients with heart failure and ICD or cardiac resynchronization therapy with defibrillator devices. All device therapies were adjudicated as either appropriate (to treat ventricular tachycardia or ventricular fibrillation) or inappropriate (all others). Remote monitoring data in the 30 days before device therapy were utilized to develop separate multivariable logistic regression and neural network models to predict appropriate device therapies. RESULTS: A total of 59,807 device transmissions were available for 2,413 patients (age 64 ± 11 years, 26% women, 64% ICD). Appropriate device therapies (141 shocks, 10 antitachycardia pacing) were delivered to 151 patients. Logistic regression identified shock lead impedance and ventricular ectopy as significantly associated with increased risk of appropriate device therapy (sensitivity 39%, specificity 91%, AUC: 0.72). Neural network modeling yielded significantly better (P < 0.01 for comparison) predictive performance (sensitivity 54%, specificity 96%, AUC: 0.90), and also identified patterns of change in atrial lead impedance, mean heart rate, and patient activity as predictors of appropriate therapies. CONCLUSIONS: Daily remote monitoring data may be utilized to predict malignant ventricular arrhythmias in the 30 days before device therapies. Neural networks complement and enhance conventional approaches to risk stratification.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ginder C, Li J, Halperin JL, et al. Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. J Am Coll Cardiol. 2023. PMID: 36889873. doi:10.1016/j.jacc.2022.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。